Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAR
1601
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.75M | ﹤0.01% |
46,300
-273,054
| -86% | -$36.1M |
|
|
KIN
1602
DELISTED
Kindred Biosciences, Inc.
KIN
| $4.73M | ﹤0.01% |
1,182,898
+3,600
| +0.3% | +$30.6K |
|
1603
Twilio
TWLO
$29.3B
| $4.72M | ﹤0.01% |
+52,795
| New | +$5.8M |
|
1604
Shore Bancshares
SHBI
$805M
| $4.71M | ﹤0.01% |
434,600
-27,753
| -6% | -$405K |
|
1605
Horace Mann Educators
HMN
$2.19B
| $4.71M | ﹤0.01% |
128,800
+2,300
| +2% | +$94.9K |
|
|
KE
1606
Kimball Electronics
KE
$635M
| $4.7M | ﹤0.01% |
430,575
+2,200
| +0.5% | +$32.8K |
|
1607
Ribbon Communications
RBBN
$376M
| $4.7M | ﹤0.01% |
1,550,800
-328,800
| -17% | -$988K |
|
1608
TechnipFMC
FTI
$27.3B
| $4.68M | ﹤0.01% |
+934,214
| New | +$10.3M |
|
1609
AC Immune
ACIU
$236M
| $4.68M | ﹤0.01% |
677,311
+189,909
| +39% | +$1.48M |
|
|
CMRX
1610
DELISTED
Chimerix, Inc.
CMRX
| $4.68M | ﹤0.01% |
3,250,013
+295,877
| +10% | +$518K |
|
|
ECHO
1611
DELISTED
Echo Global Logistics, Inc.
ECHO
| $4.67M | ﹤0.01% |
273,400
-48,400
| -15% | -$943K |
|
|
AMNB
1612
DELISTED
American National Bankshares Inc
AMNB
| $4.65M | ﹤0.01% |
194,400
-2,641
| -1% | -$85.8K |
|
1613
Lennar Class B
LEN.B
$20.1B
| $4.64M | ﹤0.01% |
168,653
+997
| +0.6% | +$43.6K |
|
|
PZN
1614
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $4.63M | ﹤0.01% |
1,038,900
+24,799
| +2% | +$174K |
|
|
OXFD
1615
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.61M | ﹤0.01% |
497,300
+81,500
| +20% | +$1.14M |
|
|
RPT
1616
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $4.6M | ﹤0.01% |
763,202
+342,102
| +81% | +$4.28M |
|
1617
Nature's Sunshine
NATR
$358M
| $4.6M | ﹤0.01% |
565,497
+3,359
| +0.6% | +$30.4K |
|
|
AGTC
1618
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.59M | ﹤0.01% |
1,398,709
+184,369
| +15% | +$971K |
|
|
MRSN
1619
DELISTED
Mersana Therapeutics
MRSN
| $4.57M | ﹤0.01% |
31,343
+2,552
| +9% | +$446K |
|
|
CHK
1620
DELISTED
Chesapeake Energy Corporation
CHK
| $4.56M | ﹤0.01% |
+131,949
| New | +$11.6M |
|
1621
Knowles
KN
$3.36B
| $4.56M | ﹤0.01% |
340,574
-216,100
| -39% | -$3.76M |
|
1622
Enerpac Tool Group
EPAC
$1.92B
| $4.55M | ﹤0.01% |
275,243
-408,450
| -60% | -$9.07M |
|
|
VRN
1623
DELISTED
Veren
VRN
| $4.55M | ﹤0.01% |
5,893,270
+2,940,343
| +100% | +$8.13M |
|
|
SEAC
1624
DELISTED
Seachange International Inc
SEAC
| $4.55M | ﹤0.01% |
61,132
-9,070
| -13% | -$693K |
|
|
ALTA
1625
DELISTED
Altabancorp
ALTA
| $4.54M | ﹤0.01% |
234,640
-1,600
| -0.7% | -$40K |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.